Figure 3 | Scientific Reports

Figure 3

From: First report on establishment and characterization of a carcinosarcoma tumour cell line model of the bladder

Figure 3

MaS-3 is most sensitive to Methotrexate, Gemcitabine and Cisplatin. (A) IC50 dose response curves of MAS-3 to 48 h treatment 5-Flourouracil, Irinotecan, Methotrexate Gemcitabine, Cisplatin, Oxaliplatin and Etoposide as calculated by non-linear regression in GraphPad Prism ver 8.0. (B) Chemosensitivity of MaS-3 cell line to the mean serum value of tested chemo drugs as identified by pubchem search (https://pubchem.ncbi.nlm.nih.gov) after 48 and 72 h of treatment. All sets were normalized to untreated controls (mean value = 1). Error bars represent standard deviation. All experiments were performed with atleast three different passages of MAS-3 and within each experiment there were six technical replicates.

Back to article page